The Orthoptic PERL

5.1 E-Scenario 2I

Certificate available: complete this course to be awarded a certificate

Not yet rated

This is an introductory module to Thyroid Eye Disease (TED). The aim is for you to further develop your theoretical knowledge and use this to help you recognise/manage TED in the clinical setting and understand why it presents this way. Please work through all sections of the scenario in the order they are presented.

Learning Objectives:

  • Revise the pathophysiology of TED
  • Consider the systemic signs and symptoms of thyroid hormone imbalance
  • Explore why and how TED occurs
  • Consider the clinical presentation of TED and the variation within this.
  • Consider the reasons for orthoptic monitoring of TED patients and the importance of your test results
  • Be aware of the indicators of disease progression that may be seen in the orthoptic clinic and the risks to the patient if this occurs.
  • Think about the aims of management in TED

Resource details

Provider's catalogue badge
Contributed by: The Orthoptic PERL
Authored by: Debbie Steel, University of Sheffield, Orthoptist, Clinical Educator
Joanne Ball, University of Liverpool, Digital
Licence: © All rights reserved More information on licences
Last updated: 28 June 2024
First contributed: 11 March 2024
Audience access level: General user

Ratings

0 ratings

Not yet rated
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
Report an issue with this resource

You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.

You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.